Your browser doesn't support javascript.
loading
The use of emerging safety biomarkers in nonclinical and clinical safety assessment - The current and future state: An IQ DruSafe industry survey.
Zabka, Tanja S; Burkhardt, John; Reagan, William J; Gautier, Jean-Charles; Glaab, Warren E; Guffroy, Magali; Harding, Joanna; Brees, Dominique; McDuffie, Eric; Ramaiah, Lila; Schultze, A Eric; Smith, James D; Wolfreys, Alison; Dalmas, Deidre A.
Affiliation
  • Zabka TS; Genentech Inc, 1 DNA Way, South San Francisco, CA, USA. Electronic address: zabka.tanja@gene.com.
  • Burkhardt J; Pfizer, 1 Eastern Point Road, Groton, CT, USA. Electronic address: john.burkhardt@pfizer.com.
  • Reagan WJ; Pfizer, 1 Eastern Point Road, Groton, CT, USA. Electronic address: william.j.reagan@pfizer.com.
  • Gautier JC; Sanofi, 13, Quai Jules Guesde, Vitry-sur-Seine, France. Electronic address: jcgautier94@gmail.com.
  • Glaab WE; Merck & Co, 770 Sumneytown Pike, West Point, PA, USA. Electronic address: warren_glaab@merck.com.
  • Guffroy M; AbbVie, 1 North Waukegan Road, North Chicago, IL, USA. Electronic address: magali.guffroy@abbvie.com.
  • Harding J; AstraZeneca, Da Vinci Building, Melbourn Science Park, Cambridge Road, Melbourn, Royston, Hertfordshire, UK. Electronic address: joanna.harding@astrazeneca.com.
  • Brees D; Novartis, 4057 Basel, Basel-stadt, Switzerland. Electronic address: dominique.brees@novartis.com.
  • McDuffie E; Janssen, 3210 Merryfield Row, San Diego, CA, USA. Electronic address: jmcduffie@its.jnj.com.
  • Ramaiah L; Pfizer, 401 North Middletown Road, Pearl River, NY, USA. Electronic address: lila.Ramaiah@pfizer.com.
  • Schultze AE; Lilly Research Laboratories, 893 S Delaware St, Indianapolis, IN, USA. Electronic address: schultze_albert_eric@lilly.com.
  • Smith JD; Boehringer Ingelheim, 900 Ridgebury Rd, Ridgefield, CT, USA. Electronic address: James-d.smith@boehringer-ingelheim.com.
  • Wolfreys A; UCB Biopharma, Bath Road, Slough, Berkshire, UK. Electronic address: alison.wolfreys@ucb.com.
  • Dalmas DA; GlaxoSmithKline, 1250 S. Collegeville Rd, Collegeville, PA, USA. Electronic address: deidre.a.dalmas@gsk.com.
Regul Toxicol Pharmacol ; 120: 104857, 2021 Mar.
Article in En | MEDLINE | ID: mdl-33387566
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Surveys and Questionnaires / Clinical Trials as Topic / Drug Industry / Drug-Related Side Effects and Adverse Reactions / Biomarkers, Pharmacological Type of study: Clinical_trials / Diagnostic_studies / Prognostic_studies Limits: Animals / Humans Language: En Journal: Regul Toxicol Pharmacol Year: 2021 Type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Surveys and Questionnaires / Clinical Trials as Topic / Drug Industry / Drug-Related Side Effects and Adverse Reactions / Biomarkers, Pharmacological Type of study: Clinical_trials / Diagnostic_studies / Prognostic_studies Limits: Animals / Humans Language: En Journal: Regul Toxicol Pharmacol Year: 2021 Type: Article